| Biodegradation of plastics–a brief review A Muthukumar, S Veerappapillai Int. J. Pharm. Sci. Rev. Res 31 (2), 204-209, 2015 | 110 | 2015 |
| Effects of risk factors for ovarian cancer in women with and without endometriosis MT Phung, A Muthukumar, B Trabert, PM Webb, SJ Jordan, KL Terry, ... Fertility and sterility 118 (5), 960-969, 2022 | 13 | 2022 |
| Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association L Khoja, RP Weber, PM Webb, SJ Jordan, A Muthukumar, ... Gynecologic oncology 164 (1), 195-201, 2022 | 12 | 2022 |
| Exploring the bioactive potential of Serriatia marcescens VITAPI (Acc: 1933637) isolated from soil A Muthukumar, P Pradeep, I Thigale, V Mohanasrinivasan, NS Jemimah, ... Frontiers in biology 11, 476-480, 2016 | 10 | 2016 |
| Human sperm DNA damage inhibition and antioxidant activity of T. arjuna bark: an in vitro study KA Rao, K Mano, M Aruna, AS Vickram, M Rameshpathy, TB Sridharan 3 Biotech 7, 1-9, 2017 | 6 | 2017 |
| WS17. 03 initiating ivacaftor (IVA) at younger vs older ages improves pulmonary outcomes in people with cystic fibrosis (pwCF): A long-term real-world study C Merlo, L McGarry, T Thorat, C Nguyen, M DerSarkissian, A Muthukumar, ... Journal of Cystic Fibrosis 21, S33-S34, 2022 | 4 | 2022 |
| Impact of age at ivacaftor initiation on pulmonary outcomes among people with cystic fibrosis CA Merlo, LJ McGarry, T Thorat, C Nguyen, M DerSarkissian, ... Thorax, 2024 | 1 | 2024 |
| Estimating the US pericarditis prevalence using national health encounter surveillance databases SA Luis, MM LeWinter, M Magestro, M DerSarkissian, MS Duh, R Chang, ... Current Medical Research and Opinion 38 (8), 1385-1389, 2022 | 1 | 2022 |
| Oxidant-antioxidant imbalance induced by influence of smoking in male fertile and infertile humans M Aruna, R Parameswari, S Vickram, B Sridharan Research journal of chemistry and environment 20 (10), 1-10, 2016 | 1 | 2016 |
| A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis C Merlo, T Thorat, LJ McGarry, CV Scirica, M DerSarkissian, C Nguyen, ... Pulmonary Therapy, 1-12, 2024 | | 2024 |
| Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost D Singer, P Thompson-Leduc, S Ma, D Gupta, WY Cheng, A Muthukumar, ... BMJ Open Respiratory Research 11 (1), e002130, 2024 | | 2024 |
| EPS6. 05 Clinical outcomes in concurrent elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) treated vs. ineligible cohorts in the US Cystic Fibrosis Foundation Patient Registry … C Merlo, H Romdhani, M DerSarkissian, A Muthukumar, L McGarry, Y Lou, ... Journal of Cystic Fibrosis 23, S51, 2024 | | 2024 |
| Treatment patterns and clinical outcomes among patients with metastatic prostate cancer harboring homologous recombination repair mutations PJ Bobbili, J Ivanova, DB Solit, NB Mettu, SJ McCall, M Dhawan, ... Clinical Genitourinary Cancer 22 (3), 102080, 2024 | | 2024 |
| Treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer harboring DDR mutations DB Solit, NB Mettu, SJ McCall, M Dhawan, PJ Bobbili, M DerSarkissian, ... Cancer Research 83 (7_Supplement), 930-930, 2023 | | 2023 |
| Abstract P4-01-30: Real-world treatment patterns and survival among adults with metastatic breast cancer with BRCA1/2 mutations P Bobbili, J Ivanova, DB Solit, N Mettu, S McCall, M Dhawan, ... Cancer Research 83 (5_Supplement), P4-01-30-P4-01-30, 2023 | | 2023 |
| Long-term durability of ivacaftor (IVA) treatment benefit in people with cystic fibrosis (PwCF) C Merlo, C Scirica, T Thorat, L Mcgarry, M Dersarkissian, C Nguyen, ... European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
| 178: Long-term impact of ivacaftor on health outcomes and mortality in people with cystic fibrosis in the US CF Foundation Patient Registry (CFFPR) C Merlo, M DerSarkissian, C Nguyen, Y Gu, A Muthukumar, L McGarry, ... Journal of Cystic Fibrosis 20, S88, 2021 | | 2021 |
| Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus … D Simmons, M DerSarkissian, R Shenolikar, MJ Wang, A Lax, ... Journal of Clinical Oncology 38 (29_suppl), 281-281, 2020 | | 2020 |
| Abstract B32: Are ovarian cancer risk factors different for women with endometriosis? A Muthukumar, L Khoja, PM Webb, H Risch, J Doherty, H Harris, ... Clinical Cancer Research 26 (13_Supplement), B32-B32, 2020 | | 2020 |
| Are ovarian cancer risk factors different for women with endometriosis? A Muthukumar, L Khoja, PM Webb, H Risch, J Doherty, H Harris, ... CLINICAL CANCER RESEARCH 26 (13), 95-95, 2020 | | 2020 |
